The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: The REQUEST study

Journal of Gastroenterology

Volumn 43, Issue 12, 2008, Pages 920-927

  Hongo, Michio ^a   Kinoshita, Yoshikazu ^b   Miwa, Hiroto ^c   Ashida, Kiyoshi ^d  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

Lansoprazole; Protonpump inhibitor; Quality of life; Reflux esophagitis

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; ROXATIDINE; STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COHORT ANALYSIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESOPHAGOSCOPY; FEMALE; HUMAN; JAPAN; LOS ANGELES CLASSIFICATION GRADE A TO D; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REFLUX ESOPHAGITIS; SAMPLE SIZE; TREATMENT DURATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGE FACTORS; AGED; ANTI-ULCER AGENTS; ESOPHAGITIS, PEPTIC; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; OBESITY; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 58149181449     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2257-7     Document Type: Article

References (27)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2005;54:710-717.
2. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398-407.
3. El-Serag HB. Time trends of gastroesophageal reflux disease: A systematic review. Clin Gastroenterol Hepatol 2007;5:17-26.
4. Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997;41:452-458.
5. Lam SK, Hasan M, Sircus W, Wong J, Ong GB, Prescott RJ. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980;21:324-328.
6. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
7. Shimazu T, Matsui T, Furukawa K, Oshige K, Mitsuyasu T, Kiyomizu, et al. A prospective study of the prevalence of gastroesophageal reflux disease and confounding factors. J Gastroenterol 2005;40:866-872.
8. Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol 1999;34:441-444.
9. Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Asan-si, Korea. Am J Gastroenterol 2005;100:747-753.
10. Chen M, Xiong L, Chen H, Xu A, He L, Hu P. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: A population-based study in South China. Scand J Gastroenterol 2005;40:759-767.
11. Yoshiike N, Kaneda F, Takimoto H. Epidemiology of obesity and public health strategies for its control in Japan. Asia Pac J Clin Nutr 2002;11(suppl 8) S727-S731.
12. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
13. Robinson M, Fitzgerald S, Hegedus R, Murthy A, Jokubaitis L; FAST Trial Investigators. Onset of symptom relief with rabeprazole: A community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther 2002;16:445-454.
14. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: An analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767-776.
15. Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese version. Kyoto: Institute for Health Outcomes & Process Evaluation Research; 2004 (in Japanese).
16. Stanghellini V, Armstrong D, Monnikes H, Bardhan KD. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther 2004;19:463-479.
17. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new diseasespecific questionnaire (QOLRAD). Eur J Surg Suppl 1998;583:41-49.
18. Macran S, Wileman S, Barton G, Russell I; REFLUX trial group. The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: The Reflux questionnaire. Qual Life Res 2007;16:331-343.
19. Klinkenberg-Knol EC, Jansen JM, Festen HP, Meuwissen SG, Lamers CB. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987;1:349-351.
20. Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, et al. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: A controlled, double-blind study. Am J Gastroenterol 1993;88:1212-1217.
21. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.
22. Hongo M. Minimal changes in reflux esophagitis: Red ones and white ones. J Gastroenterol 2006;41:95-99.
23. Yamaguchi T, Sugimoto T, Yamada H, Kanzawa M, Yano S, Yamauchi M, et al. The presence and severity of vertebral fractures is associated with the presence of esophageal hiatal hernia in postmenopausal women. Osteoporos Int 2002;13:331-336.
24. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211.
25. Ministry of Health, Labour and Welfareof Japan. The national health and nutrition survey in Japan, 2004. Tokyo: Daiichi Publishing; 2006 (in Japanese).
26. Kimura T, Tsuda Y, Uchida S, Eboshida A. Association of perceived stress and stiff neck/shoulder with health status: Multiple regression models by gender. Hiroshima J Med Sci 2006;55:101-107.
27. Fujii T, Ogino S, Arimoto H, Irifune M, Iwata N, Ookawachi I, et al. Quality of life in patients with Japanese cedar pollinosis: Using the SF-8 health status questionnaire (Japanese version) Arerugi 2006;55:1288-1294 (in Japanese with English abstract).